These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18137351)

  • 21. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiment to determine if a proguanil-resistant strain of P. falciparum would respond to large doses of pyrimethamine.
    JONES SA
    Br Med J; 1953 May; 1(4817):977. PubMed ID: 13032585
    [No Abstract]   [Full Text] [Related]  

  • 23. Proguanil-sulphonamide for malaria prophylaxis.
    Karwacki JJ; Shanks GD; Limsomwong N; Singharaj P
    Trans R Soc Trop Med Hyg; 1990; 84(1):55-7. PubMed ID: 2189248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.
    Färnert A; Tengstam K; Palme IB; Bronner U; Lebbad M; Swedberg G; Björkman A
    Am J Trop Med Hyg; 2002 May; 66(5):487-91. PubMed ID: 12201581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired resistance to proguanil in Plasmodium vivax.
    SEATON DR; LOURIE EM
    Lancet; 1949 Mar; 1(6549):394. PubMed ID: 18112625
    [No Abstract]   [Full Text] [Related]  

  • 28. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRUG-RESISTANCE IN FALCIPARUM MALARIA IN SOUTH-EAST ASIA.
    SANDOSHAM AA; EYLES DE; MONTGOMERY R
    Med J Malaya; 1964 Mar; 18():172-83. PubMed ID: 14157183
    [No Abstract]   [Full Text] [Related]  

  • 30. CYCLOGUANIL PAMOATE (CI-501) AS A CAUSAL PROPHYLACTIC AGAINST A SOUTHERN RHODESIAN STRAIN OF FALCIPARUM MALARIA.
    LUNN JS; CHIN W; CONTACOS PG; COATNEY GR
    Am J Trop Med Hyg; 1964 Nov; 13():783-5. PubMed ID: 14222428
    [No Abstract]   [Full Text] [Related]  

  • 31. Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing.
    Parzy D; Doerig C; Pradines B; Rico A; Fusai T; Doury JC
    Am J Trop Med Hyg; 1997 Dec; 57(6):646-50. PubMed ID: 9430520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of malaria chemoprophylaxis with a proguanil-chloroquine combination in Papua New Guinea.
    Henderson A; Simon JW; Melia W
    Trans R Soc Trop Med Hyg; 1986; 80(5):838-40. PubMed ID: 3299896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S; Butcher GA; Margos G; Mendoza J; Sinden RE; Høgh B
    Trans R Soc Trop Med Hyg; 2000; 94(1):77-82. PubMed ID: 10748906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of single and multiple doses of paludrine upon Plasmodium falciparum.
    RAMAKRISHNAN SP; YOUNG MD; JEFFERY GM; BURGESS RW; McLENDON SB
    Am J Hyg; 1952 Mar; 55(2):239-45. PubMed ID: 14902775
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.